Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
0(0%)
Results Posted
50%(4 trials)
Terminated
2(12%)

Phase Distribution

Ph not_applicable
4
24%
Ph phase_1
1
6%
Ph early_phase_1
2
12%
Ph phase_2
3
18%
Ph phase_3
4
24%
Ph phase_4
3
18%

Phase Distribution

3

Early Stage

3

Mid Stage

7

Late Stage

Phase Distribution17 total trials
Early Phase 1First-in-human
2(11.8%)
Phase 1Safety & dosage
1(5.9%)
Phase 2Efficacy & side effects
3(17.6%)
Phase 3Large-scale testing
4(23.5%)
Phase 4Post-market surveillance
3(17.6%)
N/ANon-phased studies
4(23.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

8 of 12 finished

Non-Completion Rate

33.3%

4 ended early

Currently Active

0

trials recruiting

Total Trials

17

all time

Status Distribution
Completed(8)
Terminated(4)
Other(5)

Detailed Status

Completed8
unknown5
Terminated2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
17
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (11.8%)
Phase 11 (5.9%)
Phase 23 (17.6%)
Phase 34 (23.5%)
Phase 43 (17.6%)
N/A4 (23.5%)

Trials by Status

terminated212%
withdrawn212%
unknown529%
completed847%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT01868269Phase 3

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

Completed
NCT00651261Phase 3

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Unknown
NCT02956070Not Applicable

Anti-inflammatory Steroids in the Prevention of Tooth Sensitivity

Completed
NCT02855866Not Applicable

Interest of Cryotherapy or Cortisone Aerosol Therapy in Early Post-operative Swallowing Disorders Following Total Thyroidectomy

Completed
NCT02419469Phase 2

Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Terminated
NCT00635154Phase 2

Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma

Completed
NCT01916252Phase 3

Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old

Completed
NCT01878708Early Phase 1

A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

Terminated
NCT01247961Phase 2

Early Treatment With Dexamethasone in Mild Acute Pancreatitis

Withdrawn
NCT01669499Phase 3

Dexamethasone for Pain Flare After Radiotherapy of Painful Bone metastasesZonMW 11510009

Completed
NCT02837614Early Phase 1

Evaluation of Preoperative Submucosal Dexamethasone in Third Molar Surgery

Completed
NCT01421173Phase 1

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

Completed
NCT02588196Phase 4

The Relationships Between Gene Polymorphisms of LTA4H and Dexamethasone Treatment for Tuberculous Meningitis

Unknown
NCT02178449Phase 4

Prolongation of Pain Free Time by the Use of Dexamethasone in Peripheral Nerve Blockade

Unknown
NCT01169415Not Applicable

Effects of Steroid Tapering on Functional Capacity and Neurocognition

Withdrawn
NCT01854515Not Applicable

Comparison of Efficacy of Nebulizing Budesonide and Intravenous Dexamethasone Before Extubation on Prevention of Post-extubation Complications in Intensive Care Unit Patients

Unknown
NCT01550146Phase 4

Single Dose of Dexamethasone in Femur Fractures

Unknown

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17